Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.

[1]  E. Cecchin,et al.  Efficacy of hepatic computed tomography to detect iron overload in chronic hemodialysis. , 1990, Kidney international.

[2]  J. Adamson,et al.  Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. , 1989, Annals of internal medicine.

[3]  R. Hakim,et al.  Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients. , 1989, Kidney international.

[4]  M. Goldman,et al.  Disorders of Iron Metabolism in the Uremic Patient , 1989 .

[5]  G. Kranias,et al.  Irreversible ocular toxicity from single "challenge" dose of deferoxamine. , 1989, Clinical nephrology.

[6]  D. Sherrard,et al.  Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  C. de Vroey,et al.  The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. , 1988, Clinical nephrology.

[8]  J. Montoliu,et al.  Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. , 1988, Clinical nephrology.

[9]  T. Nealey,et al.  Transfusion and long-term hemodialysis. , 1987, Archives of internal medicine.

[10]  B. Julian,et al.  Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. , 1987, Annals of internal medicine.

[11]  R. Hakim,et al.  Iron overload and mobilization in long-term hemodialysis patients. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  H. W. Landuyt,et al.  The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. , 1987, The Journal of infectious diseases.

[13]  C. Horváth,et al.  Extracorporeal removal of iron with immobilized desferrioxamine. , 1987, ASAIO transactions.

[14]  J. McCarthy,et al.  Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis. , 1987, The American journal of medicine.

[15]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[16]  J. Winchester.  Management of iron overload in dialysis patients. , 1986, Seminars in nephrology.

[17]  P. Keown,et al.  Removal of aluminum during hemodialysis: effect of different dialyzer membranes. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  W. Crosby.  Hemochromatosis. Treatment to alleviate injury. , 1986 .

[19]  E. Dupont,et al.  Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload. , 1986, Clinical nephrology.

[20]  J. Silver,et al.  Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  R. Sherman,et al.  Thrombocytopenia associated with intravenous desferrioxamine. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. Sondheimer,et al.  Listeriosis in patients with long-term hemodialysis and transfusional iron overload. , 1985, The American journal of medicine.

[23]  J. Vanherweghem,et al.  Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload. , 1985, British medical journal.

[24]  W. R. Anderson,et al.  Hemosiderosis and Hemochromatosis in Renal Transplant Recipients , 1985 .

[25]  H. Graf,et al.  Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results. , 1985, Contributions to nephrology.

[26]  P. Blockx,et al.  Serum ferritin as a guide for iron stores in chronic hemodialysis patients. , 1984, Kidney international.

[27]  N. Milman,et al.  Serum ferritin in patients on regular peritoneal and haemodialysis treatment: relation to marrow haemosiderin iron stores. , 1984, Danish medical bulletin.

[28]  J. A. Murray,et al.  Splenic siderosis and parenteral iron dextran in maintenance haemodialysis patients. , 1984, Journal of clinical pathology.

[29]  A. Carayon,et al.  [Does the ferritin level have a practical value in chronically hemodialized patients?]. , 1984, Nephrologie.

[30]  R. Peces,et al.  Serum ferritin in haemodialysis patients: role of blood transfusions and 'haemochromatosis alleles' HLA A3, B7 and B14. , 1984, Nephron.

[31]  N. Man,et al.  Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine. , 1984, Transactions - American Society for Artificial Internal Organs.

[32]  K. Koch,et al.  Therapy and monitoring of hypersiderosis in chronic renal insufficiency. , 1984, Contributions to nephrology.

[33]  J. de Boor,et al.  Gastrointestinal blood loss in patients undergoing maintenance dialysis. , 1983, Kidney international. Supplement.

[34]  P. Barré,et al.  EFFECT OF DESFERRIOXAMINE ON REMOVAL OF ALUMINIUM AND IRON BY COATED CHARCOAL HAEMOPERFUSION AND HAEMODIALYSIS , 1983, The Lancet.

[35]  F. Mandelli,et al.  Transfused and pharmacological iron: relationship of overload to HLA antigens. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[36]  M. Pippard,et al.  Ferrioxamine excretion in iron-loaded man. , 1982, Blood.

[37]  M. rd,et al.  Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapy. , 1982 .

[38]  A. Wr,et al.  Hemosiderosis: an unrecognized complication in renal allograft recipients. , 1982 .

[39]  A. Alarcón,et al.  Serum ferritin in haemodialysis. , 1982, Nephron.

[40]  C. Rembold,et al.  Treatment of hemodialysis hemosiderosis with desferrioxamine. , 1982, Transactions - American Society for Artificial Internal Organs.

[41]  J. Winchester,et al.  Hemosiderosis in hemodialysis patients. , 1981, JAMA.

[42]  R. Gleason,et al.  Clinical consequences of acquired transfusional iron overload in adults. , 1981, The New England journal of medicine.

[43]  I. Marino,et al.  [Deferoxamine B treatment of hemosiderosis in the anephric patient undergoing hemodialysis]. , 1981, Chirurgia e patologia sperimentale.

[44]  P. Simon,et al.  [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)]. , 1981, Nephrologie.

[45]  N. Milman,et al.  Serum ferritin and bone marrow iron in non-dialysis, peritoneal dialysis and hemodialysis patients with chronic renal failure. , 2009, Acta medica Scandinavica.

[46]  K. Lynn,et al.  Serum ferritin concentration in patients receiving maintenance hemodialysis. , 1980, Clinical nephrology.

[47]  J. Winchester,et al.  IRON-OVERLOAD-ASSOCIATED MYOPATHY IN PATIENTS ON MAINTENANCE HÆMODIALYSIS: A HISTOCOMPATIBILITY-LINKED DISORDER , 1980, The Lancet.

[48]  D. Malcolm,et al.  Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases. , 1980, JAMA.

[49]  Jimmy D Bell,et al.  Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis. , 1980, Kidney international.

[50]  J. Winchester,et al.  HLA-linked iron overload and myopathy in maintenance hemodialysis patients. , 1980, Transactions - American Society for Artificial Internal Organs.

[51]  D. Weatherall,et al.  Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. , 1979, The Quarterly journal of medicine.

[52]  G. Barbour,et al.  Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients. , 1978, Nephron.

[53]  W. Paul,et al.  Serum ferritin level. Determinant of iron requirement in hemodialysis patients. , 1977, JAMA.

[54]  P. Ackrill,et al.  Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine. , 1976, Clinical nephrology.

[55]  Brock Dj,et al.  Letter: Prospective diagnosis of spina bifida. , 1975 .

[56]  R. Longnecker,et al.  Blood loss during maintenance hemodialysis. , 1974, Transactions - American Society for Artificial Internal Organs.

[57]  E. Lowrie,et al.  The effect of total nephrectomy on hematopoiesis in patients undergoing chronic hemodialysis. , 1971, The Journal of laboratory and clinical medicine.

[58]  A. Hocken,et al.  Iatrogenic contribution to anaemia of chronic renal failure. , 1971, Lancet.

[59]  A. Stragier,et al.  Effect of bilateral nephrectomy on transfusion requirements of patients undergoing chronic dialysis. , 1969, Lancet.

[60]  D. Mattingly,et al.  HOW MANY LADDERS? , 1964, Lancet.